What AI says about Abeona Therapeutics

Abeona Therapeutics Inc. is a commercial stage biopharmaceutical company developing cell and gene therapies for serious diseases, with its product ZEVASKYN® approved for recessive dystrophic epidermolysis bullosa. The company's pipeline includes PSMA SIR T™, an engineered T cell therapy targeting prostate cancer, and is supported by its own cGMP manufacturing facility in Cleveland.